Health By Andrew Joseph U.S. reports 180 cases of unexplained hepatitis in children, as researchers investigate potential causes
Biotech By Jonathan Wosen ‘No real clear path’: Insurance coverage for cutting-edge diagnostics remains a major challenge for personalized medicine
Pharmalot By Ed Silverman Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others
First Opinion By Michael L. Millenson and J. Matthew Austin To improve safety, hospitals should make ‘radical transparency’ real — and accessible
First Opinion By Steven C. Schlozman Hopelessness around youth mental health is creating a ‘nihilistic contagion’
Health By Olivia Goldhill Vague ‘medical emergency’ exceptions in abortion laws leave pregnant people in danger, doctors say
Business By Rebecca Robbins The insulin market is heading for a shakeup. But patients may not benefit
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: FDA staff questions effectiveness of Merck antibiotic
Pharmalot By Ed Silverman Gilead won’t have to pay $200 million in patent case because Merck lawyer lied
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Investors tell pharma to ‘take control’ of the pricing debate
The Pharmalot View By Ed Silverman Big drug maker presses for money-back guarantee that its science will work
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: China probing drug and device makers for antitrust violations
Pharmalot By Ed Silverman Switching to newest HPV vaccine can save billions in health care costs, study says
Pharmalot By Ed Silverman Pharmalot, Pharmalittle: Gilead ordered to pay $200m to Merck in patent row